Convalescent Plasma in the treatment of 6 COVID-19 Patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000033056

Enrollment

Unknown

Registered

2020-05-19

Start date

2020-01-29

Completion date

Unknown

Last updated

2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Convalescent Plasma of COVID-19 patients

Eligibility

Sex/Gender

All

Age

51 Years to 84 Years

Inclusion criteria

Inclusion criteria: 1. Recurrent COVID-19 patients; 2. The COVID-19 patients with Long treatment cycle.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

Measure	Time frame
Duration of negative changes;	—

Countries

China

Contacts

Public ContactZhang Wei

Affiliated Hospital of Zunyi Medical University

zhangwei_hxicu@163.com+86 18982262419

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026